Q3 2020 HTG Molecular Diagnostics Inc Earnings Call Transcript
Greetings, and welcome to the HTG Molecular Diagnostics, Inc. Third Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Paul Arndt with LifeSci Advisors. Thank you. You may begin.
Thank you, operator. Earlier today, HTG released its financial results for the third quarter ended September 30, 2020.
Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding increasing use of RNA-based biomarkers; expected growth in the molecular profiling market; anticipated growth in the company's RUO profiling business and related revenue; expectations regarding biopharma programs and collaborations; product development and commercialization activities; and the impact of and potential recovery from the ongoing COVID-19 pandemic.
These forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |